Single-domain antibodies as crystallization chaperones to enable structure-based inhibitor development for RBR E3 ubiquitin ligases
More about Open Access at the CrickAuthors list
Isabella Tsai Henrik Johansson David Dixon Stephen Martin Chun-Wa Chung Jane Clarkson David House Katrin RittingerAbstract
Protein ubiquitination plays a key role in the regulation of cellular processes, and misregulation of the ubiquitin system is linked to many diseases. So far, development of tool compounds that target enzymes of the ubiquitin system has been slow and only a few specific inhibitors are available. Here, we report the selection of single-domain antibodies (single-dAbs) based on a human scaffold that recognize the catalytic domain of HOIP, a subunit of the multi-component E3 LUBAC and member of the RBR family of E3 ligases. Some of these dAbs affect ligase activity and provide mechanistic insight into the ubiquitin transfer mechanism of different E2-conjugating enzymes. Furthermore, we show that the co-crystal structure of a HOIP RBR/dAb complex serves as a robust platform for soaking of ligands that target the active site cysteine of HOIP, thereby providing easy access to structure-based ligand design for this important class of E3 ligases.
Journal details
Journal Cell Chemical Biology
Volume 27
Issue number 1
Pages 83-93.e9
Available online
Publication date
Full text links
Publisher website (DOI) 10.1016/j.chembiol.2019.11.007
Figshare View on figshare
Europe PubMed Central 31813847
Pubmed 31813847
Keywords
Related topics
Type of publication